Research animal retirement and lifetime care, now available through Alpha Genesis. Professionally managed lifetime care for retired research primates, with expert social reintroduction into stable outdoor groups led by veterinary staff deeply experienced in laboratory-animal medicine.
Learn moreServices
End-to-end GLP/IND-enabling and non-GLP preclinical study support across rodent and NHP models, with rapid study initiation to get your program moving, built for pharmaceutical, biotechnology, academic, and government research programs and trusted by sponsors across the United States, Europe, and Asia.
Alpha Genesis provides integrated preclinical contract research services for sponsors seeking scientifically rigorous, welfare-centered in vivo study execution. Our capabilities span rodent and NHP platforms, enabling sponsors to progress from early proof-of-concept through translational safety and efficacy studies within a single, experienced research partner. We work with multinational pharmaceutical and biotechnology sponsors and design studies to support global regulatory development programs, with documentation suitable for international submissions.
Our study portfolio includes pharmacology, pharmacokinetics and pharmacodynamics (PK/PD), dose-ranging and tolerability assessments, acute and repeat-dose toxicology, biodistribution, immunology, vaccine immunogenicity, infectious disease, biodefense models, oncology, neuroscience, surgical and interventional models, and biospecimen collection. GLP-aligned documentation and IND-enabling support are available, with study design tailored to sponsor protocol and regulatory context, including studies intended to fit a global regulatory strategy.
Beyond our in-house capabilities, Alpha Genesis works with an extensive network of trusted specialty partners, spanning bioanalysis and bioanalytical chemistry, histopathology and clinical pathology, formulation, specialized assays, imaging, and more, and coordinates them seamlessly on your behalf. Sponsors get a single point of contact and one integrated program, without the overhead of managing multiple vendors.
Reliable data begins with healthy, well-managed animals. Board-certified laboratory-animal veterinarians, experienced animal-care teams, environmental enrichment, and preventive-medicine programs keep study animals physiologically and behaviorally stable, the conditions under which results are most reproducible. That care operates within a federally recognized animal-care and compliance program, including AAALAC accreditation, USDA registration, OLAW Assurance, and IACUC oversight, with SOP-driven operations that keep programs inspection-ready. Compliance is expected; the depth of our veterinary and husbandry program is what differentiates the data we deliver.
Our preclinical CRO platform is designed to meet the operational and scientific needs of a broad range of research sponsors.
Drug developers seeking GLP and non-GLP in vivo study support across small molecules, biologics, vaccines, and advanced therapeutics, from early discovery through IND-enabling programs where applicable.
Emerging and established biotech sponsors requiring flexible, responsive preclinical CRO capabilities with veterinary oversight and defined study timelines.
University investigators and research centers conducting NIH, NSF, or foundation-funded in vivo studies requiring compliant animal care and technical study support.
Federal and defense research programs, including biodefense, infectious disease, and vaccine development, requiring experienced NHP and rodent study execution under appropriate oversight frameworks.
Contract research organizations and multi-site consortia seeking a reliable NHP and rodent research partner for overflow capacity, specialized species access, or program co-execution.
Our preclinical CRO platform encompasses a broad range of in vivo study types, matched to your program.
Alpha Genesis supports preclinical research across both rodent and NHP platforms, providing translational study continuity within a single research partner.
Inbred, outbred, and transgenic mouse and rat models for pharmacology, PK/PD, toxicology, immunology, oncology, and custom in vivo studies. Rodent capabilities support early-stage programs and IND-enabling work.
The most widely used NHP model for translational pharmacology, vaccines, infectious disease, immunology, and neuroscience research. Rhesus macaques offer well-characterized immunological and physiological profiles highly relevant to human biology.
Frequently selected for pharmaceutical safety, toxicology, and biologic development programs. Cynomolgus macaques are a primary NHP species in IND-enabling and regulatory safety studies.
A distinctive NHP model with particular relevance to infectious disease, biodefense, and select immunological research programs. Alpha Genesis maintains an established African green monkey program.
Capuchin monkeys are available for select neuroscience, behavioral, and specialized research programs, supported by experienced veterinary and husbandry teams.
Beyond our core species, Alpha Genesis can and has supported additional models, including spider monkeys, pigtail macaques, baboons, and marmosets, through custom programs. Talk to us about translational model fit for your study.
Preclinical study execution at Alpha Genesis integrates experienced technical teams across dosing, sampling, monitoring, and surgical endpoints.
Scientific rigor and exceptional animal care drive study quality at Alpha Genesis. Board-certified laboratory-animal veterinarians provide medical direction, preventive health management, and 24/7/365 clinical monitoring throughout each study, supported by experienced veterinary technicians and animal-care teams, environmental enrichment, and SOP-driven operations that protect both animal welfare and data integrity. Dedicated study directors and complete electronic documentation keep programs ready for sponsor and regulatory inspection. This work is backed by a federally recognized animal-care and compliance program, including AAALAC accreditation, USDA registration, OLAW Assurance, and IACUC oversight. GLP and non-GLP study support is available, with GLP-aligned documentation and IND-enabling study design consistent with sponsor regulatory strategy. Our quality systems are consistent with internationally recognized GLP expectations, and our teams are experienced supporting global regulatory development programs, consistently generating high-quality data to support submissions to major health authorities, including the FDA, EMA, MHRA, PMDA, and others, where appropriate. GLP study support is provided with documentation consistent with 21 CFR Part 58, and, where electronic records and signatures are used, with 21 CFR Part 11. Applicability is confirmed per program.
Getting a study underway is fast and straightforward. Responsive feasibility review, ready colonies and study infrastructure, and direct access to experienced study teams let us move from inquiry to study initiation quickly, so your program isn't waiting on capacity or setup.
Exceptional animal care, board-certified veterinary leadership, experienced animal-care teams, and enrichment science, backed by AAALAC accreditation, produces healthier, more behaviorally consistent animals and more reproducible data. Compliance is expected; the quality of our animal care is what differentiates the study data we deliver.
Decades of NHP colony management, study execution, and health-program development have produced institutional expertise that is difficult to replicate. Our NHP teams understand species-specific physiology, behavior, and data variability in ways that directly benefit study design and execution.
Board-certified laboratory-animal veterinarians and experienced veterinary staff provide medical oversight at every stage, from protocol review through terminal procedures. Veterinary judgment is integrated into study conduct, not applied only when problems arise.
Sponsors can initiate early-stage rodent pharmacology and PK/PD studies at Alpha Genesis and advance translational NHP work within the same research relationship, preserving institutional knowledge, protocol consistency, and sponsor-team familiarity across program phases.
Alpha Genesis has supported large-scale government biodefense and infectious disease programs alongside commercial pharmaceutical and biotechnology sponsors. This operational breadth means our teams are experienced with complex multi-cohort designs, long-duration studies, and stringent regulatory documentation frameworks.
Alpha Genesis is experienced supporting multinational pharmaceutical and biotechnology sponsors. Dedicated scientific project managers, international project coordination, worldwide sample management and shipping, and secure electronic data transfer make it straightforward to run a study from across the country or across an ocean. We are comfortable working within both U.S. and international regulatory expectations and design programs that fit a global regulatory strategy.
Yes. Alpha Genesis offers GLP and non-GLP study support. GLP-aligned documentation and IND-enabling study execution are available and aligned to sponsor protocol and regulatory context. Our quality systems are consistent with internationally recognized GLP expectations, and we consistently generate high-quality data to support global regulatory development programs. We recommend discussing your specific program requirements during an initial feasibility consultation.
Our scientific and business development teams are available to discuss study feasibility, species availability, protocol design, and timeline. Contact us to begin the conversation.
